More tools:Markets·Screener·Research·Chat

Aura Biosciences, Inc. Common Stock (AURA) Financial Statements

Aura Biosciences, Inc. Common Stock
SIC 2836 · BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)
FIGI BBG00226DGP2
XNAS · usd
7.26▼ 0.10 (-1.36%)
As of 2026-09-09
Valuation
Market Cap
Enterprise Value
Trailing P/E—
Price / Sales—
EV / Revenue—
EV / EBITDA
Financial Highlights
Revenue (TTM)—
Net Income (TTM)
EBITDA
Diluted EPS (TTM)
EBITDA Margin—
Net Debt
Trading Information
Previous Close7.36
Day's Range7.28 – 7.56
52-Week Range4.73 – 9.54
Volume505.3K
Avg Volume714.7K
Share Statistics
Shares Outstanding
Employees113
ExchangeXNAS
Listed2021-10-29
Share count as of August 6, 2026
Loading Income Statement…
Key questions about Aura Biosciences, Inc. Common Stock (AURA)
What is Aura Biosciences, Inc. Common Stock's Market Cap?
Aura Biosciences, Inc. Common Stock's Market Cap is $752.9M, based on as-reported figures from SEC (XBRL) filings.
What is Aura Biosciences, Inc. Common Stock's Enterprise Value?
Aura Biosciences, Inc. Common Stock's Enterprise Value is $685.1M, based on as-reported figures from SEC (XBRL) filings.
What is Aura Biosciences, Inc. Common Stock's EV / EBITDA?
Aura Biosciences, Inc. Common Stock's EV / EBITDA is n/m, based on as-reported figures from SEC (XBRL) filings.
What is Aura Biosciences, Inc. Common Stock's Net Income (TTM)?
Aura Biosciences, Inc. Common Stock's Net Income (TTM) is -$131.0M, based on as-reported figures from SEC (XBRL) filings.
What is Aura Biosciences, Inc. Common Stock's EBITDA?
Aura Biosciences, Inc. Common Stock's EBITDA is -$137.0M, based on as-reported figures from SEC (XBRL) filings.
What is Aura Biosciences, Inc. Common Stock's Diluted EPS (TTM)?
Aura Biosciences, Inc. Common Stock's Diluted EPS (TTM) is -1.26, based on as-reported figures from SEC (XBRL) filings.
What is Aura Biosciences, Inc. Common Stock's Net Debt?
Aura Biosciences, Inc. Common Stock's Net Debt is -$67.8M, based on as-reported figures from SEC (XBRL) filings.
Showing the most recent year. Subscribe for full statement history.
Income Statement(in thousands of USD, except per-share data)
Source: Akyla.ai
Line ItemJun 30, 2026Mar 31, 2026Dec 31, 2025Sep 30, 2025Jun 30, 2025Mar 31, 2025Dec 31, 2024Sep 30, 2024Jun 30, 2024Mar 31, 2024Dec 31, 2023Sep 30, 2023Jun 30, 2023Mar 31, 2023Dec 31, 2022Sep 30, 2022
Operating Expenses:
Research and development
General and administrative
Total operating expenses
Total operating loss
Other income (expense):
Interest income, including amortization and accretion income
Other income (expense)
Total other income
Loss before income taxes
Income tax provision, net
Net loss
Net loss per common share - basic
Net loss per common share - diluted